Prescient Therapeutics
South Melbourne
About Prescient Therapeutics
Prescient Therapeutics (PTX) is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of solid and hematological cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2014)
- Ticker: asx:PTX
- Website: ptxtherapeutics.com
- Phone: +61396927222
Industries & Categories
Biopharma, Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/prescient-therapeutics-701443 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.